Lack of Toll-like receptor 4 or myeloid differentiation factor 88 reduces atherosclerosis and alters plaque phenotype in mice deficient in apolipoprotein E - Wikidata - wikimedia - TriplyDB

Lack of Toll-like receptor 4 or myeloid differentiation factor 88 reduces atherosclerosis and alters plaque phenotype in mice deficient in apolipoprotein E

Lack of Toll-like receptor 4 or myeloid differentiation factor 88 reduces atherosclerosis and alters plaque phenotype in mice deficient in apolipoprotein E

http://www.wikidata.org/entity/Q36986664

about

Mediators of inflammation in polycystic ovary syndrome in relation to adiposity Atherosclerosis and infection: is the jury still not in?Unexpected protective role for Toll-like receptor 3 in the arterial wall Regulated accumulation of desmosterol integrates macrophage lipid metabolism and inflammatory responses CD36 ligands promote sterile inflammation through assembly of a Toll-like receptor 4 and 6 heterodimer Targeted inhibition of STATs and IRFs as a potential treatment strategy in cardiovascular disease High-Risk Cardiovascular Patients: Clinical Features, Comorbidities, and Interconnecting Mechanisms Cigarette Smoke Amplifies Inflammatory Response and Atherosclerosis Progression Through Activation of the H1R-TLR2/4-COX2 Axis Role of gut microbiota in the modulation of atherosclerosis-associated immune response Adiponectin as a potential biomarker of vascular disease Oxidation-specific epitopes and immunological responses: Translational biotheranostic implications for atherosclerosis Chemokines and microRNAs in atherosclerosis Endothelial dysfunction: the role of sterol regulatory element-binding protein-induced NOD-like receptor family pyrin domain-containing protein 3 inflammasome in atherosclerosis Lipids and the endothelium: bidirectional interactions The biology of atherosclerosis: general paradigms and distinct pathogenic mechanisms among HIV-infected patients Genetically modified mouse models for the study of nonalcoholic fatty liver disease Noncoding RNAs regulate NF-κB signaling to modulate blood vessel inflammation The SYK side of TLR4: signalling mechanisms in response to LPS and minimally oxidized LDL S100A8 and S100A9 in cardiovascular biology and disease Toll-like receptor-2 mediates diet and/or pathogen associated atherosclerosis: proteomic findings Trypanosoma cruzi infection is a potent risk factor for non-alcoholic steatohepatitis enhancing local and systemic inflammation associated with strong oxidative stress and metabolic disorders The Role of TLR2, TLR4, and TLR9 in the Pathogenesis of Atherosclerosis Gut Microbiome and Obesity: A Plausible Explanation for Obesity Inflammatory cell recruitment in cardiovascular disease: murine models and potential clinical applications Polyoxygenated cholesterol ester hydroperoxide activates TLR4 and SYK dependent signaling in macrophages.The Vascular Endothelial Growth Factor Inhibitors Ranibizumab and Aflibercept Markedly Increase Expression of Atherosclerosis-Associated Inflammatory Mediators on Vascular Endothelial Cells Lgr4/Gpr48 negatively regulates TLR2/4-associated pattern recognition and innate immunity by targeting CD14 expression The protective effect of A20 on atherosclerosis in apolipoprotein E-deficient mice is associated with reduced expression of NF-kappaB target genes A genome-wide association analysis reveals 1p31 and 2p13.3 as susceptibility loci for Kawasaki disease.Sterile inflammation: sensing and reacting to damage Contribution of vascular cell-derived cytokines to innate and inflammatory pathways in atherogenesis.Vascular cells contribute to atherosclerosis by cytokine- and innate-immunity-related inflammatory mechanisms.Human oral, gut, and plaque microbiota in patients with atherosclerosis.Data mining of atherosclerotic plaque transcriptomes predicts STAT1-dependent inflammatory signal integration in vascular disease.Role of NOD2/CARD15 in coronary heart disease.Comprehensive analysis of the candidate genes CCL2, CCR2, and TLR4 in age-related macular degeneration Absence of p55 TNF receptor reduces atherosclerosis, but has no major effect on angiotensin II induced aneurysms in LDL receptor deficient mice Islet endothelial activation and oxidative stress gene expression is reduced by IL-1Ra treatment in the type 2 diabetic GK rat MyD88-dependent and independent pathways of Toll-Like Receptors are engaged in biological activity of Triptolide in ligand-stimulated macrophages Leukocyte Trafficking in Cardiovascular Disease: Insights from Experimental Models

P2860

Q21296837-2317E25B-8EF0-4D5A-9321-50E5E638B4A0 Q22241306-FE1B671F-AC1F-4342-A1C7-D7999C129E60 Q24624935-E66D3E0D-B734-4701-BE35-AD1DF97506AB Q24631052-6EE96F8F-1949-4604-949E-E26150042028 Q24642646-73BEB186-07FB-406A-9659-510E38591BD9 Q26750725-EED117D3-152B-4924-A4BE-608170B42BDF Q26774658-E683A78A-0771-47A0-85AB-C362983FD820 Q26776119-DC7F8B5A-CF00-4D38-A243-32801570A496 Q26801649-F6BAF910-7AD9-42EF-B0F2-91A5E6D2F2D8 Q26821925-4B5E3CEE-682B-42C6-9449-80010ED3073A Q26822962-0A7AEFE5-26D1-422E-862B-9AC2D676410D Q26852545-2CC53433-4A0F-439D-8BCC-E79E91B4C031 Q26852572-682AC420-425B-4A53-AD98-C117E81A62C1 Q26860086-6D763358-15B4-4377-AEFA-3DF69F3CBF16 Q26862601-F730FEFE-A6D0-4F44-BFE1-9FDD5EBF0A05 Q26865248-845A6108-51D6-43E2-ADD0-54C6D9401391 Q26865593-FBF2EC94-D858-4D99-B84A-820DF3148F59 Q26991782-C1314E17-508D-450C-95E0-B2786E6ABD3E Q27024450-31A58D2A-251D-4E1D-BBD1-1A83B53A7B6E Q27300289-FFD10872-DB29-4242-A596-9BB6CEE73830 Q27304622-5C220042-CDFA-4A33-B2DC-0BD9013CD79E Q28077737-4D55976F-5FCC-428D-A987-E312109696C6 Q28087145-038848D4-E002-469A-B429-CAFC6511F7E6 Q28275259-751E8395-8AA1-4ED5-9D4F-1AC59161EB53 Q28537901-16DBD8A8-61DF-4017-81A9-B625EE96C80F Q28550616-6EFF843C-C5DA-46F3-A686-E7F93ED873AD Q28591315-B7DB9B98-EDED-49C9-BAC0-28F55E6D8752 Q28594304-2852312E-8E63-4BDC-BA1C-3C1C7481C2B7 Q29417090-16A7A986-24EF-4CBF-B89A-CD49C4DF93C7 Q29620014-B439082A-EF7D-4003-8781-E49E23C6DCB5 Q30318502-7D72963C-BBAE-42DA-8675-2FF833F1BD92 Q30319434-8EB8CC4D-36E2-47A4-A691-C91B78CC5560 Q30499024-0DC6C5FE-2FEF-4BC4-A272-B3867B5B7044 Q30848049-1A5FEF2B-6896-41DB-989E-75360B2002FE Q33304877-3FBF57D2-82E2-413D-8B83-B45443B018B4 Q33313069-2BFD7E51-9E60-43B4-BEA3-A0DF3CA77BBC Q33479145-D57F1265-E39D-4169-8055-B7A5D44AA048 Q33501717-4C3C7244-8183-4661-9453-0C6A1CCC2E73 Q33552853-4F81AC7D-F2ED-4E10-8A13-5CD5CE7867B2 Q33561481-1C271019-70E5-46CA-AED3-19000B60B040

P2860

Lack of Toll-like receptor 4 or myeloid differentiation factor 88 reduces atherosclerosis and alters plaque phenotype in mice deficient in apolipoprotein E

http://www.wikidata.org/entity/Q36986664

description

2004 nî lūn-bûn

@nan

2004年の論文

@ja

2004年論文

@yue

2004年論文

@zh-hant

2004年論文

@zh-hk

2004年論文

@zh-mo

2004年論文

@zh-tw

2004年论文

@wuu

2004年论文

@zh

2004年论文

@zh-cn

name

Lack of Toll-like receptor 4 o ...... deficient in apolipoprotein E

@en

type

label

Lack of Toll-like receptor 4 o ...... deficient in apolipoprotein E

@en

prefLabel

Lack of Toll-like receptor 4 o ...... deficient in apolipoprotein E

@en

P1433

Q36986664-28100D6E-88EB-49E4-9789-DA22AE84929E

P1476

Q36986664-C93B782F-6371-4EBD-98DA-C5DC4550D9A7

P2093

Q36986664-37D6E888-09F4-4BBA-802F-6BC7A43FADB5

Q36986664-3D94EBF8-FD78-41C2-BFED-9D142DA35C06

Q36986664-77FD43CE-5C20-474C-99CA-614E74A6E85F

Q36986664-79AF8A52-FE82-47B0-966E-8C79EAD3D95A

Q36986664-81DC6F72-2CD4-4BA9-965B-A21D4EC5DFCC

Q36986664-BC39A75E-98BC-4F37-AE25-6882ECFA8101

Q36986664-D0E3353B-8432-42CD-B8C0-87BEBE888DE6

Q36986664-FB184465-48AD-4EB5-B8D5-FA9E49FB5C5C

P2860

Q36986664-01406756-0514-4170-B0E8-DC98B0A926EB

Q36986664-095AB696-48A7-4DDE-A14D-405E315C069B

Q36986664-1026EAFC-F919-4965-B038-8E2A2CE8C264

Q36986664-120A88CD-FC5A-47DB-AB98-81D5E01EAF27

Q36986664-13BE5801-1FC3-4E9F-9D6D-5FA3EC5E3B8F

Q36986664-164E0E61-6F2D-4AF5-9FCD-142CB8F66337

Q36986664-1BF11801-CFE3-43E7-AA76-742A8362BCE9

Q36986664-2CB85BE1-8A72-484F-8C26-204D044B0457

Q36986664-318CFC82-EAB1-4248-AFBA-EC48418FBCBA

Q36986664-31E5EC5C-1364-44CD-B333-76130E0F2CBA

P304

Q36986664-483BE40D-AFF3-4663-A716-FB941AAA3770

P31

Q36986664-64FDA61A-7DF3-4BE1-A7C6-A6C32503AA77

P356

Q36986664-14E06A0D-BDA0-4690-B7AF-944BF3296B30

P407

Q36986664-C067A5AB-5593-4761-BDC1-B825D9BCFF8C

P433

Q36986664-456553C4-6315-40F0-93BB-CF398ABC3586

P478

Q36986664-76773DE7-921E-4FBC-8392-33642D52081F

P50

Q36986664-92DE1E81-EC1B-4AED-8EAD-DF70F0A556AB

P577

Q36986664-B3E5B0B9-7A8A-41B5-A33C-9E20BFDB0085

P5875

Q36986664-94052033-43CE-4C0A-9489-02700C69B7BA

P698

Q36986664-4D94BCE8-0D9C-46E9-AE75-79B3B23FEFBA

P921

Q36986664-B8D1F52A-96A7-4633-A9E8-BD394935DBE5

Q36986664-F404F62B-5149-4B1B-88C9-504BBDCB42A4

P932

Q36986664-C07D29F0-9E67-417B-B2F3-915DCBAFEA7F

P356

PNAS.0403249101

P1433

Proceedings of the National Academy of Sciences of the United States of America

P1476

Lack of Toll-like receptor 4 o ...... deficient in apolipoprotein E

@en

P2093

Juliana Yano

http://www.w3.org/2001/XMLSchema#string

Kathrin S Michelsen

http://www.w3.org/2001/XMLSchema#string

Michelle H Wong

http://www.w3.org/2001/XMLSchema#string

Prediman K Shah

http://www.w3.org/2001/XMLSchema#string

Shizuo Akira

http://www.w3.org/2001/XMLSchema#string

Terence M Doherty

http://www.w3.org/2001/XMLSchema#string

Tripathi B Rajavashisth

http://www.w3.org/2001/XMLSchema#string

Wenxuan Zhang

http://www.w3.org/2001/XMLSchema#string

P2860

TLR4 mutations are associated with endotoxin hyporesponsiveness in humans

Defective LPS Signaling in C3H/HeJ and C57BL/10ScCr Mice: Mutations in Tlr4 Gene

Atherosclerosis — An Inflammatory Disease

Recognition of double-stranded RNA and activation of NF-kappaB by Toll-like receptor 3

Murine TOLL-like receptor 4 confers lipopolysaccharide responsiveness as determined by activation of NF kappa B and expression of the inducible cyclooxygenase

NF-kappaB: pivotal mediator or innocent bystander in atherogenesis?

Human toll-like receptors mediate cellular activation by Mycobacterium tuberculosis

Inflammation in atherosclerosis

CD14, a receptor for complexes of lipopolysaccharide (LPS) and LPS binding protein

Inflammation and atherosclerosis

P304

10679-10684

http://www.w3.org/2001/XMLSchema#string

P31

scholarly article

P356

10.1073/PNAS.0403249101

http://www.w3.org/2001/XMLSchema#string

P407

P433

29

http://www.w3.org/2001/XMLSchema#string

P478

101

http://www.w3.org/2001/XMLSchema#string

P50

P577

2004-07-12T00:00:00Z

http://www.w3.org/2001/XMLSchema#dateTime

P5875

8458994

http://www.w3.org/2001/XMLSchema#string

P698

15249654

http://www.w3.org/2001/XMLSchema#string

P921

atherosclerosis

Toll-like receptor

P932

489994

http://www.w3.org/2001/XMLSchema#string